173 related articles for article (PubMed ID: 10430973)
1. Echocardiographic evaluation in patients with autosomal dominant polycystic kidney disease and end-stage renal disease.
Martinez-Vea A; Bardají A; Gutierrez C; Garcia C; Peralta C; Aguilera J; Sanchez P; Vidiella J; Angelet P; Compte T; Richart C; Oliver JA
Am J Kidney Dis; 1999 Aug; 34(2):264-72. PubMed ID: 10430973
[TBL] [Abstract][Full Text] [Related]
2. Cardiac involvement in autosomal-dominant polycystic kidney disease: a hypertensive heart disease.
Bardají A; Martinez-Vea A; Valero A; Gutierrez C; Garcia C; Ridao C; Oliver JA; Richart C
Clin Nephrol; 2001 Sep; 56(3):211-20. PubMed ID: 11597036
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.
Martinez-Vea A; Valero FA; Bardaji A; Gutierrez C; Broch M; Garcia C; Richart C; Oliver JA
Am J Nephrol; 2000; 20(3):193-200. PubMed ID: 10878400
[TBL] [Abstract][Full Text] [Related]
4. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.
Christophe JL; van Ypersele de Strihou C; Pirson Y
Nephrol Dial Transplant; 1996 Jul; 11(7):1271-6. PubMed ID: 8672022
[TBL] [Abstract][Full Text] [Related]
5. Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease.
Valero FA; Martinez-Vea A; Bardají A; Gutierrez C; Garcia C; Richart C; Oliver JA
J Am Soc Nephrol; 1999 May; 10(5):1020-6. PubMed ID: 10232688
[TBL] [Abstract][Full Text] [Related]
6. Mitral valve calcification as an index of left ventricular dysfunction in patients with end-stage renal disease on peritoneal dialysis.
Hüting J
Chest; 1994 Feb; 105(2):383-8. PubMed ID: 8306733
[TBL] [Abstract][Full Text] [Related]
7. Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state.
Martinez-Vea A; Bardaj A; Gutierrez C; Garca C; Peralta C; Marcas L; Oliver JA
Am J Kidney Dis; 2004 Aug; 44(2):216-23. PubMed ID: 15264179
[TBL] [Abstract][Full Text] [Related]
8. [Echocardiographic changes in patients with polycystic nephropathy].
Guidali PL; Bertoni PD; Canziani R; Chiringhelli S; Denna V; Cozzi G; Filippini G
Minerva Cardioangiol; 1992 Jun; 40(6):219-24. PubMed ID: 1407616
[TBL] [Abstract][Full Text] [Related]
9. Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease.
Oflaz H; Alisir S; Buyukaydin B; Kocaman O; Turgut F; Namli S; Pamukcu B; Oncul A; Ecder T
Kidney Int; 2005 Nov; 68(5):2244-9. PubMed ID: 16221225
[TBL] [Abstract][Full Text] [Related]
10. [ADPKD and Heart].
Liut F; Izzi C; Dallera N; Scolari F
G Ital Nefrol; 2017 Mar; 34(Suppl 69):119-130. PubMed ID: 28682033
[TBL] [Abstract][Full Text] [Related]
11. Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.
De Almeida EA; Prata MM
Rev Port Cardiol; 2007 Nov; 26(11):1173-82. PubMed ID: 18297839
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Chapman AB; Johnson AM; Rainguet S; Hossack K; Gabow P; Schrier RW
J Am Soc Nephrol; 1997 Aug; 8(8):1292-7. PubMed ID: 9259356
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease.
Bardají A; Vea AM; Gutierrez C; Ridao C; Richart C; Oliver JA
Am J Kidney Dis; 1998 Dec; 32(6):970-5. PubMed ID: 9856512
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner.
Pietrzak-Nowacka M; Safranow K; Czechowska M; Dutkiewicz G; Kornacewicz-Jach Z; Ciechanowski K
Kidney Blood Press Res; 2012; 36(1):301-9. PubMed ID: 23235185
[TBL] [Abstract][Full Text] [Related]
15. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.
Schrier R; McFann K; Johnson A; Chapman A; Edelstein C; Brosnahan G; Ecder T; Tison L
J Am Soc Nephrol; 2002 Jul; 13(7):1733-9. PubMed ID: 12089368
[TBL] [Abstract][Full Text] [Related]
16. Extrarenal manifestations of autosomal dominant polycystic kidney disease.
Ha SK; Park CH; Kna JS; Lee SY; Lee JI; Kim SJ; Seo JK; Lee HY; Han DS
Yonsei Med J; 1997 Apr; 38(2):111-6. PubMed ID: 9175489
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients.
Takeda K; Nakamoto M; Baba M; Tanaka T; Yasunaga C; Nishihara G; Matsuo K; Urabe M
Clin Nephrol; 1998 May; 49(5):308-12. PubMed ID: 9617495
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease.
Ivy DD; Shaffer EM; Johnson AM; Kimberling WJ; Dobin A; Gabow PA
J Am Soc Nephrol; 1995 Jun; 5(12):2032-6. PubMed ID: 7579051
[TBL] [Abstract][Full Text] [Related]
19. Epicardial Fat Thickness in Patients with Autosomal Dominant Polycystic Kidney Disease.
Concistrè A; Petramala L; Scoccia G; Sciomer S; Bisogni V; Saracino V; Iannucci G; Lai S; Mastroluca D; Iacobellis G; Letizia C
Cardiorenal Med; 2018; 8(3):199-207. PubMed ID: 29723863
[TBL] [Abstract][Full Text] [Related]
20. Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients.
Cannella G; Paoletti E; Ravera G; Cassottana P; Araghi P; Mulas D; Peloso G; Delfino R; Messa P
Kidney Int; 2000 Jul; 58(1):260-8. PubMed ID: 10886571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
